Patents by Inventor Neetu Dayal

Neetu Dayal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240208971
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: December 21, 2023
    Publication date: June 27, 2024
    Inventors: Herman O. Sintim, Neetu Dayal, Clemen Opoku-Temeng
  • Patent number: 11891391
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: February 6, 2024
    Assignee: Purdue Research Foundation
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Publication number: 20230312562
    Abstract: The present invention generally relates to tetrahydro-3H-pyrazolo-[4,3-f]-quinolone and tetrahydro-3H-pyrrolo-[3,2-f]quinoline-containing compounds as a tubulin polymerization inhibitor for the treatment of various cancers, and methods of uses thereof. Pharmaceutical compositions and the methods for treating those kinase related diseases are within the scope of this invention.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 5, 2023
    Applicant: Purdue Research Foundation
    Inventors: Herman O. Sintim, Neetu Dayal
  • Publication number: 20230219934
    Abstract: The present invention generally relates to 2,3-Disubstituted pyrido[3,4-b]pyrazine-containing compounds as a kinase inhibitor and methods of uses thereof. Pharmaceutical compositions and methods for treating those kinase related diseases are within the scope of this invention.
    Type: Application
    Filed: June 24, 2021
    Publication date: July 13, 2023
    Applicant: Purdue Research Foundation
    Inventors: Herman O. Sintim, Elizabeth Anne Larocque, Delmis E. Hernandez, Neetu Dayal
  • Publication number: 20210371420
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: April 29, 2021
    Publication date: December 2, 2021
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Patent number: 11040973
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: June 22, 2021
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng
  • Publication number: 20200308173
    Abstract: The present invention generally relates to compounds as a dual kinase-demethylase inhibitor useful for the treatment of diseases mediated by a kinase and/or a histone demethylase, such as inflammation, cancer, viral and bacterial infections, neurological and immunological disorders. Pharmaceutical compositions and methods for treating those diseases are within the scope of this invention.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 1, 2020
    Inventors: Herman O. Sintim, Neetu Dayal, Clement Opoku-Temeng